Uncovering Hidden Signals: Sleep, Mobility and Social Patterns in Depression via Digital Phenotyping

Bingham Bonilla^*
*Correspondence: Bingham Bonilla, Department of Medicine, University of California, San Francisco, USA, Email:

Introduction

Depression is a pervasive mental health disorder that affects millions of people globally. It is often characterized by persistent feelings of sadness, hopelessness, and a loss of interest in once-pleasurable activities. Beyond its emotional and psychological effects, depression significantly impacts an individualâ??s cognitive and physical functions, which can be difficult to measure with traditional diagnostic methods. For many individuals, depression can be a fluctuating condition with symptoms that change over time, and its impact can be subtle, especially during the early stages. This makes it difficult to assess the full extent of depression through intermittent clinical visits, self-report questionnaires, and other traditional forms of assessment. As a result, there has been increasing interest in finding new ways to monitor depression in real-time and across multiple dimensions of behavior, such as sleep, mobility, and social interaction. One such promising approach is digital phenotyping, which uses mobile devices and wearable sensors to passively collect data on an individual's behaviors and physiological states. By capturing information on sleep patterns, movement, and social interactions, digital phenotyping can offer valuable insights into the subtle and often hidden signals of depression that might otherwise go unnoticed [1].

Description

Digital phenotyping refers to the use of real-time data gathered from smartphones, wearables, and other sensors to assess and monitor an individual's mental health. Unlike traditional clinical assessments that rely on periodic check-ins or self-reporting, digital phenotyping allows for continuous and objective measurement of behavior and physiological processes. These data are gathered passively, meaning they are collected without the need for active input from the individual, providing a more naturalistic view of their daily functioning. In the case of depression, digital phenotyping can reveal patterns of behavior that are indicative of the disorder but may not be immediately visible through conventional means. Sleep disturbances, for example, are common in individuals with depression, yet they often go unnoticed until they become severe. Reduced mobility and social withdrawal are also core features of depression but can be difficult to quantify. With digital phenotyping, devices such as smartphones and wearables can track these behavioral changes continuously, offering new ways to assess depression beyond the clinical setting [2].

The relationship between depression and changes in sleep patterns is well-documented, with many individuals experiencing insomnia or hypersomnia as part of their depressive symptoms. Sleep disruptions are often one of the first signs of depression and can be both a cause and a consequence of the disorder. Poor sleep can exacerbate symptoms of depression, while depression can interfere with the ability to maintain a regular sleep schedule. Traditional methods of assessing sleep, such as self-reported sleep diaries or clinical evaluations, are often subjective and prone to biases. Digital phenotyping, however, provides a more objective measure of sleep, with wearables such as actigraphy bands or smartphones equipped with motion sensors capable of tracking sleep duration, quality, and sleep-wake patterns. These devices can provide a detailed picture of an individualâ??s sleep behaviors over time, enabling clinicians to identify early signs of depression before they are reported by the individual. Furthermore, continuous monitoring of sleep data can offer insights into how sleep disturbances evolve during depressive episodes, providing valuable information for treatment decisions [3].

Another key aspect of depression is the reduction in physical activity, which is often coupled with an overall decline in mobility. People with depression commonly experience fatigue, lack of energy, and a diminished ability to engage in daily tasks, leading to a decrease in overall movement. This reduction in mobility can further worsen the individual's mood and contribute to the feeling of hopelessness that is so often associated with the disorder [4]. Digital phenotyping can track mobility and physical activity in a continuous, non-invasive way, using accelerometers and GPS sensors found in smartphones and wearables. These devices can measure step count, activity levels, and even the amount of time spent in various locations, such as at home or in public spaces. By assessing changes in movement patterns over time, clinicians can gain a better understanding of how depression impacts a personâ??s daily functioning. For example, a noticeable decrease in mobility may signal the onset or worsening of depressive symptoms, while an increase in activity after treatment may indicate an improvement in mood or a positive response to therapy [5].

Conclusion

In conclusion, digital phenotyping holds immense promise in uncovering hidden signals of depression by leveraging passive sensing technologies to monitor sleep, mobility, and social patterns. By continuously tracking these behaviors, digital phenotyping can provide a more accurate, real-time, and comprehensive understanding of how depression affects an individualâ??s daily life. This approach allows for early detection of depressive symptoms, better monitoring of treatment progress, and more personalized care. As technology continues to advance, digital phenotyping has the potential to transform the way we diagnose, treat, and manage depression, offering new hope for individuals struggling with this debilitating disorder. However, as with any emerging technology, further research and careful consideration of ethical and privacy concerns will be necessary to fully realize its potential in clinical practice.

Acknowledgment

None.

6.Conflict of Interest

None.

References

1. Jacobson, Nicholas C., Berta Summers and Sabine Wilhelm. "Digital biomarkers of social anxiety severity: Digital phenotyping using passive smartphone sensors." J Med Internet Res 22 (2020): e16875.

Google Scholar Cross Ref

2. Barnett, Ian, John Torous, Patrick Staples and Luis Sandoval, et al. "Relapse prediction in schizophrenia through digital phenotyping: A pilot study." Neuropsychopharmacology 43 (2018): 1660-1666.

Google Scholar Cross Ref Indexed at

3. Kleiman, Evan M., Brianna J. Turner, Szymon Fedor and Eleanor E. Beale, et al. "Digital phenotyping of suicidal thoughts." Depress Anxiety35 (2018): 601-608.

Google Scholar Cross Ref Indexed at

4. Ozomaro, Uzoezi, Claes Wahlestedt and Charles B. Nemeroff. "Personalized medicine in psychiatry: Problems and promises." MC Med 11 (2013): 1-35.

Google Scholar Cross Ref Green Version

5. Perna, G., M. Grassi, D. Caldirola and C. B. Nemeroff. "The revolution of personalized psychiatry: Will technology make it happen sooner?." Psychol Med 48 (2018): 705-713.

Google Scholar Cross Ref